Infection  >>  MG1109  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MG1109 / GC Biopharma
NCT01389466: Study to Evaluate the Safety and Immunogenicity of MG1109 in Healthy Adult Volunteers

Completed
1/2
346
RoW
Step 1, Step 2
Green Cross Corporation, Korean Center for Disease Control and Prevention
Influenza
11/11
12/11

Download Options